We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
The COURAGE trial showed no substantial difference in cardiovascular outcomes among patients who received either optimal medical therapy or optimal therapy plus a percutaneous intervention. Dr. William Weintraub, professor of medicine at Chrisitana Care Health System in Newark, Delaware, describes his cost-benefit analysis of this trial and how cost effectiveness should be measured and evaluated in this patient population. Hosted by Dr. Matthew Sorrentino.
The COURAGE trial showed no substantial difference in cardiovascular outcomes among patients who received either optimal medical therapy or optimal therapy plus a percutaneous intervention. Dr. William Weintraub, professor of medicine at Chrisitana Care Health System in Newark, Delaware, describes his cost-benefit analysis of this trial and how cost effectiveness should be measured and evaluated in this patient population. Hosted by Dr. Matthew Sorrentino.
Stay current with the best on medical education
